Fiasp is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Aspart.
| Product ID | 0169-3205_0d8112c7-3e31-4272-911f-06e803633178 |
| NDC | 0169-3205 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Fiasp |
| Generic Name | Insulin Aspart Injection |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2018-09-24 |
| Marketing Category | BLA / NDA |
| Application Number | BLA208751 |
| Labeler Name | Novo Nordisk |
| Substance Name | INSULIN ASPART |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [CS],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-10-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208751 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-10-30 |
| Marketing Category | NDA |
| Application Number | NDA208751 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-10-01 |
| Marketing Category | NDA |
| Application Number | NDA208751 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-10-01 |
| Marketing Category | NDA |
| Application Number | NDA208751 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-10-30 |
| Ingredient | Strength |
|---|---|
| INSULIN ASPART | 100 [iU]/mL |
| SPL SET ID: | 834e7efc-393f-4c55-9125-628562a8a5cf |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0169-3201 | Fiasp | insulin aspart injection |
| 0169-3204 | Fiasp | insulin aspart injection |
| 0169-3205 | Fiasp | insulin aspart injection |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FIASP 79162960 4966787 Live/Registered |
Novo Nordisk A/S 2015-02-09 |
![]() FIASP 79140450 4541341 Live/Registered |
Novo Nordisk A/S 2013-10-28 |